Wolfgang Wick

发表

Deep Probabilistic Modeling of Glioma Growth

Klaus H. Maier-Hein, Fabian Isensee, Martin Bendszus, 2019, MICCAI.

DNA methylation-based classification of central nervous system tumours

Till Acker, Pieter Wesseling, Martin Sill, 2018, Nature.

Adult precision medicine: learning from the past to enhance the future

Duane A. Mitchell, Wolfgang Wick, Ashley Ghiaseddin, 2020, Neuro-oncology advances.

Continuous-Time Deep Glioma Growth Models pdf

Fabian Isensee, Martin Bendszus, Jens Petersen, 2021, MICCAI.

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

Oliver Jäkel, Thomas Haberer, Lutz Edler, 2010, BMC Cancer.

Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma

Ferdinand Schweser, Alexander Radbruch, Benedikt Wiestler, 2013, PloS one.

Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions

Stefan M. Pfister, Damian Stichel, Andreas von Deimling, 2019, Acta Neuropathologica.

Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion.

Marcel Leist, Michael Weller, Wolfgang Wick, 2002, Cancer research.

Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.

Jacoline E. C. Bromberg, Michael Platten, Martin Bendszus, 2016 .

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients

Sebastian Bickelhaupt, Daniel Paech, Alexander Radbruch, 2018, Oncotarget.

Radiologic progression of glioblastoma under therapy—an exploratory analysis of AVAglio

Michael Platten, Alexander Radbruch, Martin Bendszus, 2018, Neuro-oncology.

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Martin Sill, Michael Platten, Volker Hovestadt, 2017, The Lancet. Oncology.

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Michael Weller, Wolfgang Wick, Guido Reifenberger, 2012, Neuro-oncology.

A novel tool to analyze MRI recurrence patterns in glioblastoma.

Chris Rorden, Michael Platten, Hans-Otto Karnath, 2008, Neuro-oncology.

Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with newly diagnosed Glioblastoma using Quantitative Susceptibility Mapping ( QSM )

Ferdinand Schweser, Alexander Radbruch, Martin Bendszus, 2011 .

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.

Martin Glas, Michael Weller, Johannes Rieger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brain metastases: pathobiology and emerging targeted therapies

Frank Winkler, Matthias Preusser, Wolfgang Wick, 2012, Acta Neuropathologica.

Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets

Stefan M. Pfister, Ivo Buchhalter, Benedikt Wiestler, 2016, Acta Neuropathologica.

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

Volker Hovestadt, Stefan M. Pfister, Felix Sahm, 2015, Acta Neuropathologica.

Nuclear Overhauser Enhancement Mediated Chemical Exchange Saturation Transfer Imaging at 7 Tesla in Glioblastoma Patients

Daniel Paech, Alexander Radbruch, Peter Bachert, 2014, PloS one.

Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology

Daniel Paech, Alexander Radbruch, Peter Bachert, 2015, PloS one.

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.

Martin Sill, Michael Platten, Volker Hovestadt, 2014, Neuro-oncology.

Lomustine and Bevacizumab in Progressive Glioblastoma

Martin Klein, Michael Platten, Martin Bendszus, 2017, The New England journal of medicine.

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Gabriele Schackert, Markus Loeffler, Hans Binder, 2015, Acta Neuropathologica.

Association of overall survival in patients with newly diagnosed glioblastoma with contrast‐enhanced perfusion MRI: Comparison of intraindividually matched T1‐ and T2*‐based bolus techniques

David Bonekamp, Alexander Radbruch, Benedikt Wiestler, 2015, Journal of magnetic resonance imaging : JMRI.

Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study.

Carsten Rother, Daniel Paech, Alexander Radbruch, 2019, Investigative radiology.

The Potential of Relaxation-Weighted Sodium Magnetic Resonance Imaging as Demonstrated on Brain Tumors

Wolfhard Semmler, Alexander Radbruch, Michael Bock, 2011, Investigative radiology.

Michael Platten, Daniel Schwarz, Martin Bendszus, 2016, eLife.

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Marion Smits, Bradley J Erickson, Jayashree Kalpathy-Cramer, 2015, Neuro-oncology.

Suberoylanilide hydroxamic acid (SAHA) has potent anti‐glioma properties in vitro, ex vivo and in vivo

Rudolf Fahlbusch, Ingmar Blümcke, Michael Weller, 2005, Journal of neurochemistry.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Martin Glas, Michael Sabel, Jörg-Christian Tonn, 2019, The Lancet.

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO

Pieter Wesseling, Jaap C. Reijneveld, Volker Hovestadt, 2015, Acta Neuropathologica.

Quantification of Tumor Vessels in Glioblastoma Patients Using Time-of-Flight Angiography at 7 Tesla: A Feasibility Study

Daniel Paech, Alexander Radbruch, Sina Burth, 2014, PloS one.

Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria.

Alexander Radbruch, Benedikt Wiestler, Martin Bendszus, 2012, Neuro-oncology.

High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol

Alexander Radbruch, Martin Bendszus, Heinz-Peter Schlemmer, 2015, Investigative radiology.

Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response

Martin Sill, Michael Götz, David Bonekamp, 2016, Clinical Cancer Research.

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP

Naoya Hashimoto, Enrico Franceschi, Ashok Panigrahy, 2015 .

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

Michael Weller, Wolfgang Wick, Simone Fulda, 2002, Nature Medicine.

Clinical trial end points for high-grade glioma: the evolving landscape.

Timothy F Cloughesy, Mark R Gilbert, Wolfgang Wick, 2011, Neuro-oncology.

Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T

Sebastian Bickelhaupt, Daniel Paech, Alexander Radbruch, 2018, Neuro-oncology.

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?

Andreas von Deimling, Jürgen Debus, Stephanie E Combs, 2011, Radiation oncology.

Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.

Martin Sill, David Bonekamp, Alexander Radbruch, 2016, Radiology.

Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling

Gabriele Schackert, Andreas von Deimling, Markus Loeffler, 2014, International journal of cancer.

Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma

Alexander Radbruch, Benedikt Wiestler, Martin Bendszus, 2014, Neurology.

Standards of care for treatment of recurrent glioblastoma--are we there yet?

Michael Weller, Wolfgang Wick, M. Weller, 2013, Neuro-oncology.

K27M-mutant histone-3 as a novel target for glioma immunotherapy

Michael Platten, Andreas von Deimling, Felix Sahm, 2017, Oncoimmunology.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma

Brigitta G. Baumert, Jaap C. Reijneveld, Andreas von Deimling, 2016, The Lancet. Oncology.

Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting

Alexander Radbruch, Karl Kiening, Sina Burth, 2016, PloS one.

Michael Platten, Martin Bendszus, Andreas von Deimling, 2019, Front. Neurosci..

Pathway inhibition: emerging molecular targets for treating glioblastoma.

Michael Platten, Michael Weller, Wolfgang Wick, 2011, Neuro-oncology.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Christian Mawrin, Michael Weller, Christian Hartmann, 2009, Acta Neuropathologica.

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma

Stefan M. Pfister, Damian Stichel, Felix Sahm, 2018, Acta Neuropathologica.

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

Martin Sill, Volker Hovestadt, Stefan M. Pfister, 2018, Acta Neuropathologica.

Treatment of anaplastic glioma.

Michael Platten, Benedikt Wiestler, Wolfgang Wick, 2015, Cancer treatment and research.

Downfield‐NOE‐suppressed amide‐CEST‐MRI at 7 Tesla provides a unique contrast in human glioblastoma

Daniel Paech, Alexander Radbruch, Peter Bachert, 2017, Magnetic resonance in medicine.

KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.

Alexander Hoischen, Wolfgang Wick, Gerald Seifert, 2012, Brain : a journal of neurology.

cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

Pieter Wesseling, Caterina Giannini, David N. Louis, 2018, Acta Neuropathologica.

Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.

Alexander Radbruch, Benedikt Wiestler, Martin Bendszus, 2014, Radiology.

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

Naoya Hashimoto, Enrico Franceschi, Ashok Panigrahy, 2015, The Lancet. Oncology.

ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA

Donald M. O'Rourke, John H. Sampson, Michael Lim, 2016 .

T1ρ-weighted Dynamic Glucose-enhanced MR Imaging in the Human Brain.

Sebastian Bickelhaupt, Daniel Paech, David Bonekamp, 2017, Radiology.

Shaping the glioma immune microenvironment through tryptophan metabolism.

Michael Platten, Michael Weller, Wolfgang Wick, 2012, CNS oncology.

Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β

Michael Platten, Michael Weller, Wolfgang Wick, 2001, Journal of Neuro-Oncology.

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

Martin Sill, Alexander Radbruch, Volker Hovestadt, 2014, Acta Neuropathologica.

Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology

Sebastian Bickelhaupt, Alexander Radbruch, Karl Kiening, 2017, PloS one.